IP Library Granted Patent US 10,654,882
Granted Patent B2
US 10,654,882 · App. 15/777,756 · Granted May 19, 2020

Nicotinamide mononucleotide derivative and salt thereof, method for producing same, topical skin preparation, cosmetic and food additive

Inventor: Daisuke Yagyu (Ichihara, JP)
Assignee: SHOWA DENKO K.K.
C07H19/048A23L29/00A23L33/13A61K8/60A61K8/606A61K31/706A61Q19/00A61Q19/08A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,654,882
App. No.
15/777,756
Granted
May 19, 2020
Kind
B2
Abstract

The present invention provides a nicotinamide mononucleotide derivative, or salt thereof, which is a compound represented by general formula (1), wherein R 1 and R 2 respectively and independently represent a hydrogen atom or acyl group having 3 to 30 carbon atoms, the hydrocarbon group bound to the carbonyl carbon of the acyl group is a linear or branched, saturated or unsaturated hydrocarbon group, and at least one of R 1 and R 2 is the acyl group.

Claims (10)

1. A nicotinamide mononucleotide derivative, or salt thereof, which is a compound represented by general formula (1):

wherein, R 1 and R 2 respectively and independently represent a hydrogen atom or an acyl group having 3 to 30 carbon atoms, wherein the hydrocarbon group bound to the carbonyl carbon of the acyl group is a linear or branched, saturated or unsaturated hydrocarbon group, and at least one of R 1 and R 2 is an acyl group.

2. The nicotinamide mononucleotide derivative, or salt thereof, according to claim 1 , wherein R 1 and R 2 in the general formula (1) respectively and independently represent an acyl group having 6 to 16 carbon atoms.

3. The nicotinamide mononucleotide derivative, or salt thereof, according to claim 1 , wherein the salt of the compound of the general formula (1) is a salt formed with one or more types of anions selected from the group consisting of: nitrate ions, sulfate ions, carbonate ions, bicarbonate ions, halide ions, formate ions, acetate ions, citrate ions, tartrate ions, oxalate ions, fumarate ions, anions of saturated or unsaturated fatty acids having 3 to 20 carbon atoms, anions of carnitine, anions of hydroxycitric acid, anions of ascorbic acid, and anions of ascorbyl phosphate.

4. The nicotinamide mononucleotide derivative, or salt thereof, according to claim 1 , wherein the salt of the compound of the general formula (1) is a salt formed with one or more types of cations selected from the group consisting of: sodium ions, potassium ions, calcium ions, magnesium ions, zinc ions, ammonium ions, and cations of carnitine.

5. A method for producing the nicotinamide mononucleotide derivative, or salt thereof, according to claim 1 , comprising: acylating nicotinamide mononucleotide with one or more types of acylating agents selected from the group consisting of: carboxylic acids having an acyl group having 3 to 30 carbon atoms, in which a linear or branched, saturated or unsaturated hydrocarbon group is bound to the carbonyl carbon; a halide of the carboxylic acid, and an anhydride of the carboxylic acid, in a solvent containing 20% by weight or more of a strongly acidic liquid having pK a of 2.0 or less.

6. The method for producing the nicotinamide mononucleotide derivative, or salt thereof, according to claim 5 , wherein the strongly acidic liquid is trifluoroacetic acid or sulfuric acid.

7. A nicotinamide mononucleotide derivative-containing or nicotinamide mononucleotide derivative salt-containing topical skin composition comprising the nicotinamide mononucleotide derivative, or a salt thereof, according to claim 1 , and optionally one or more additional ingredients suitable for the topical skin composition.

8. A nicotinamide mononucleotide derivative-containing or nicotinamide mononucleotide derivative salt-containing cosmetic comprising the topical skin composition according to claim 7 , and optionally one or more additional ingredients suitable for the cosmetic.

9. A nicotinamide mononucleotide derivative-containing or nicotinamide mononucleotide derivative salt-containing food additive comprising the nicotinamide mononucleotide derivative, or a salt thereof, according to claim 1 , and optionally one or more additional ingredients suitable for the food additive.

Assignments (3)
CHANGE OF ADDRESS Recorded Feb 14, 2024
From: RESONAC CORPORATION
To: RESONAC CORPORATION
Reel/Frame 066599/0037 →
CHANGE OF NAME Recorded Jun 23, 2023
From: SHOWA DENKO K.K.
To: RESONAC CORPORATION
Reel/Frame 064082/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2018
From: YAGYU, DAISUKE
To: SHOWA DENKO K.K.
Reel/Frame 045863/0576 →
Priority Claims (1)
JP 2015-249020 · Dec 21, 2015 · national
Continuity (1)
Related Publication 20180334474A1 · Nov 22, 2018